APA (7th ed.) Citation

J, C., A, V., HH, L., H, W., M, S., RR, R., . . . G, E. (2023). A review of evidence for pneumococcal vaccination in adults at increased risk of pneumococcal disease: Risk group definitions and optimization of vaccination coverage in the United Kingdom. Expert review of vaccines, 22(1), 785. https://doi.org/10.1080/14760584.2023.2256394

Chicago Style (17th ed.) Citation

J, Campling, et al. "A Review of Evidence for Pneumococcal Vaccination in Adults at Increased Risk of Pneumococcal Disease: Risk Group Definitions and Optimization of Vaccination Coverage in the United Kingdom." Expert Review of Vaccines 22, no. 1 (2023): 785. https://doi.org/10.1080/14760584.2023.2256394.

MLA (9th ed.) Citation

J, Campling, et al. "A Review of Evidence for Pneumococcal Vaccination in Adults at Increased Risk of Pneumococcal Disease: Risk Group Definitions and Optimization of Vaccination Coverage in the United Kingdom." Expert Review of Vaccines, vol. 22, no. 1, 2023, p. 785, https://doi.org/10.1080/14760584.2023.2256394.